Stay updated with breaking news from Nasdaq Grts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides bought 12,000 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were bought at an average cost of $1.90 per share, with a total value of $22,800.00. Following the transaction, the insider now directly owns 214,058 shares of the company’s […]
Gritstone bio, Inc. (NASDAQ:GRTS – Get Rating) insider Vassiliki Economides acquired 12,000 shares of Gritstone bio stock in a transaction dated Tuesday, May 23rd. The shares were purchased at an average price of $1.90 per share, with a total value of $22,800.00. Following the acquisition, the insider now owns 214,058 shares of the company’s stock, […]
B. Riley started coverage on shares of Gritstone bio (NASDAQ:GRTS – Get Rating) in a research report released on Tuesday, Marketbeat reports. The firm issued a buy rating and a $8.00 target price on the stock. B. Riley also issued estimates for Gritstone bio’s Q1 2023 earnings at ($0.32) EPS, Q2 2023 earnings at ($0.35) […]
Equities research analysts at B. Riley started coverage on shares of Gritstone bio (NASDAQ:GRTS – Get Rating) in a research note issued on Tuesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the stock. B. Riley’s price target indicates a potential upside of 200.75% from the stock’s previous […]
EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...